Molecular Diagnostics of Methicillin-Resistant Staphylococcus aureus

The emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA) represent a profound challenge to public health worldwide. Molecular diagnostics have transformed the detection and management of MRSA by enabling rapid, sensitive and specific identification of resistance determinants directly from clinical specimens. At the core of most assays lies the detection of the mecA gene or its gene product, penicillin-binding protein 2a (PBP2a), often carried on staphylococcal cassette chromosome mec (SCCmec) elements. Polymerase chain reaction (PCR)-based methods, ranging from single-plex to multiplex formats, allow simultaneous identification of species-specific markers (such as nuc or spa) and resistance genes, shortening turnaround time from days to hours. Point-of-care platforms integrate automated DNA extraction, amplification and read-out, facilitating early therapeutic decisions and infection-control measures. Isothermal amplification techniques (for example loop-mediated isothermal amplification) have further simplified workflows by obviating thermocyclers. Advances in whole-genome sequencing now permit high-resolution typing and comprehensive resistome profiling, informing outbreak investigation and surveillance. More recently, biosensor technologies leveraging nanomaterials, nucleic-acid enzymes (DNAzymes) and field-effect transistors have been shown to detect MRSA at single-colony-forming unit sensitivity without culture. Collectively, these molecular approaches underpin antimicrobial stewardship, reduce empirical broad-spectrum therapy and enhance epidemiological tracking of MRSA lineages in hospital and community settings.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Molecular Diagnostics of Methicillin-Resistant Staphylococcus aureus publication trend

The graph below shows the total number of articles in molecular diagnostics of methicillin-resistant staphylococcus aureus across all publications each year (not limited to Nature Index journals).

Technical terms

mecA gene: The gene encoding penicillin-binding protein 2a (PBP2a), conferring resistance to β-lactam antibiotics.

SCCmec: Mobile genetic element carrying mecA and regulatory genes, defining MRSA lineages.

Polymerase chain reaction (PCR): Enzymatic method for exponential amplification of specific DNA sequences.

Loop-mediated isothermal amplification (LAMP): A single-temperature nucleic-acid amplification technique offering rapid and robust detection.

Field-effect transistor (FET) biosensor: Electronic sensor that transduces biomolecular interactions into electrical signals.

DNAzyme: Catalytic DNA molecule engineered to cleave specific RNA or DNA targets, enhancing assay specificity.

Whole-genome sequencing (WGS): High-throughput method to determine the complete DNA sequence of an organism for detailed resistome and phylogenetic analysis.

References

1. Controllable self-cleaning FET self-assembled RNA-cleaving DNAzyme based DNA nanotree for culture-free Staphylococcus aureus detection. Journal of Nanobiotechnology (2024).
2. Prospective Evaluation of the BD MAX StaphSR Assay for the Screening of Methicillin-Susceptible and -Resistant Staphylococcus aureus from Nasal Swabs Taken in Intensive Care Unit Patients. International Journal of Molecular Sciences (2023).
3. Recent Developments in Phenotypic and Molecular Diagnostic Methods for Antimicrobial Resistance Detection in Staphylococcus aureus: A Narrative Review. Diagnostics (2022).
4. Laboratory-Based and Point-of-Care Testing for MSSA/MRSA Detection in the Age of Whole Genome Sequencing. Frontiers in Microbiology (2018).